Bioclinica
Clario (formerly Bioclinica) is a global provider of clinical trial technology and services, offering electronic clinical outcome assessments, cardiac safety, medical imaging, and other endpoint data collection solutions to pharmaceutical, biotech, and medical device companies. The company supplies cloud-based platforms, devices, and expert services that help sponsors and CROs design, run, and analyze clinical trials more efficiently and in compliance with regulatory standards. It generates revenue through software licensing, technology-enabled services, and professional consulting engagements for clinical research programs.
- Clinical Trial & Research Software
- IT Consulting & Implementation
- Revenue
- $650.0M
- Employees
- 3,000
- Founded
- 1972
- Headquarters
- Blue Bell, United States of America
What 59 Arbolus experts think of Bioclinica
NPS scores indicate strong positive sentiment with most respondents scoring 8–10, two Promoters (score 10), and only a few indicating Detractors or Passives (scores 3–6). Renewal intent is high among key influencers and high spenders, with only isolated uncertainty or planned offboarding. Stickiness is reflected in the fact that 85% of experts report using Bioclinica for over a year, typically in core workflow functions. Key expert themes highlight integration, operational reliability, and support as major strengths, with occasional mentions of delays or manual effort as negatives.Overall Customer Sentiment: Positive
Who reviewed Bioclinica
- C-Suite 60% (35)
- Director 28% (17)
- Manager 12% (7)
Employer names and spend open in the full report, along with the other 56 customers.
Everything 59 customers told us about Bioclinica.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
25 Net Promoter Score, from 59 scored reviews- Promoters 27
- Passives 20
- Detractors 12
Cumulative NPS by month
+0 over 6 months- May 8
- Jun 8
- Jul 8
- Aug 8
- Sep 8
- Oct 8
Net Promoter Score across 4 reviews, accumulated up to each month. Category median 26 across 4 companies.
Praised
- Faster Review and Query Resolution
- Greater Automation and Integration
- AI-Driven Workflow Enhancement
- Imaging Assessment Specialization
Criticised
- Integration Complexity and Overlap
- Manual Data Review Still Needed
- Delayed Reviews and Manual Steps
- Operational Support and Commercial Terms
What customers say
Renewal intent
Plan to renew 48%Plan to renew, by seniority
- 53% 19 answers
- 33% 9 answers
- 50% 2 answers
- 100% 1 answer
- 8.1/10 Average score from customers who will renew
- 7.5/10 Average score from undecided customers
- 6/10 Average score from customers not renewing
Top alternatives
Most weighed by Bioclinica customers
Report
More in Data & Analytics and Consulting & Professional Services
Other companies in both categories with a customer report.
For people who use Bioclinica
Do you use Bioclinica at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 59 customers of Bioclinica have already contributed
Takes a few minutes. Your identity stays anonymous.